If you need more lookups,
subscriptions start at $34 USD/month.
Lucienne Ide Location
Atlanta, GA, US
Lucienne Ide Work
Chief Medical Officer @ (March 2026 - Present)
Member and Board Director @ (January 2026 - Present)
Member @ (January 2019 - Present)
Founder and CEO @ (March 2012 - March 2026)
Class of 2022 @ (January 2022 - December 2022)
Resident, Obstetrics and Gynecology @ (June 2009 - October 2010)
Medical Scientist Training Program (MD and PhD) @ (January 2002 - January 2007)
Research assistant @ (January 2001 - January 2002)
Signals analyst @ (January 1997 - January 2000)
Associate @ Monarch Capital Partners (January 2000 - January 2000)
Lucienne Ide Education
Emory University
MD/PhD (Molecular and Systems Pharmacology)
2002-2009
Middlebury College
BA (Physics, Spanish)
1993-1997
Westminster Schools 1980-1993
Lucienne Ide Skills
Cell
Stem Cells
Lifesciences
Pharmacology
Public Speaking
Protein Chemistry
DNA
Analysis
Healthcare
Clinical Research
Medicine
Biotechnology
Laboratory
Cell Culture
Cancer
Cell Biology
Molecular Biology
Research
Genetics
Competitive Analysis
Immunology
Life Sciences
Strategy
Strategic Planning
Management
Business Development
Business Strategy
Entrepreneurship
Leadership
Fast Healthcare Interoperability Resources (FHIR)
Health Policy
Healthcare Information Technology (HIT)
Product Development
Microsoft Word
Sales
Data Analysis
Microsoft Office
PowerPoint
Lucienne Ide Summary
Lucienne Ide, based in Atlanta, GA, US, is currently a Chief Medical Officer at Health Recovery Solutions. Lucienne Ide brings experience from previous roles at Dooley's Angels, Women Business Leaders of the US Health Care Industry Foundation (WBL), Rimidi and Leadership Georgia. Lucienne Ide holds a 2002 - 2009 MD/PhD in Molecular and Systems Pharmacology @ Emory University. With a robust skill set that includes Cell, Stem Cells, Lifesciences, Pharmacology, Public Speaking and more. Lucienne Ide has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Lucienne Ide?
Find contact details for 700 million professionals.